Umthong Supawadee, Timilsina Uddhav, D'Angelo Mary R, Salka Kyle, Stavrou Spyridon
Department of Microbiology and Immunology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, United States of America.
Department of Biochemistry and Microbiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
PLoS Pathog. 2024 Jul 29;20(7):e1012330. doi: 10.1371/journal.ppat.1012330. eCollection 2024 Jul.
Membrane-associated RING-CH (MARCH) 2 is a member of the MARCH protein family of RING-CH finger E3 ubiquitin ligases that play important roles in regulating the levels of proteins found on the cell surface. MARCH1, 2 and 8 inhibit HIV-1 infection by preventing the incorporation of the envelope glycoproteins into nascent virions. However, a better understanding of the mechanism utilized by MARCH proteins to restrict HIV-1 infection is needed. In this report, we identify an amino acid in human MARCH2, absent in mouse MARCH2, critical for its antiretroviral function. Moreover, we map the domains of human MARCH2 critical for restricting as well as binding to the HIV-1 envelope glycoproteins. In addition, we demonstrate that MARCH2 is present inside nascent virions and reduces particle infectivity by blocking virus entry in a RING-CH-independent manner. Finally, we show that MARCH2 acts as an HIV-1 restriction factor only in primary CD4+ T cells and can prevent cell-to-cell transmission of HIV-1. Our findings reveal important new aspects of the antiviral mechanism utilized by human MARCH2 to restrict HIV-1 that have potential implications to all MARCH proteins with antiviral functions and their viral targets.
膜相关的RING-CH(MARCH)2是RING-CH指型E3泛素连接酶的MARCH蛋白家族成员,在调节细胞表面蛋白水平方面发挥重要作用。MARCH1、2和8通过阻止包膜糖蛋白掺入新生病毒颗粒来抑制HIV-1感染。然而,需要更好地理解MARCH蛋白用于限制HIV-1感染的机制。在本报告中,我们鉴定出人类MARCH2中一个小鼠MARCH2中不存在的氨基酸,该氨基酸对其抗逆转录病毒功能至关重要。此外,我们绘制了人类MARCH2中对限制以及结合HIV-1包膜糖蛋白至关重要的结构域。另外,我们证明MARCH2存在于新生病毒颗粒内部,并通过以RING-CH非依赖方式阻断病毒进入来降低颗粒感染性。最后,我们表明MARCH2仅在原代CD4+T细胞中作为HIV-1限制因子起作用,并可防止HIV-1的细胞间传播。我们的发现揭示了人类MARCH2用于限制HIV-1的抗病毒机制的重要新方面,这对所有具有抗病毒功能的MARCH蛋白及其病毒靶点具有潜在影响。